Avanos Medical
AVNS
286 hedge funds and large institutions have $548M invested in Avanos Medical in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 96 increasing their positions, 65 reducing their positions, and 30 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 65
33% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 30
3% more funds holding
Funds holding: 277 → 286 (+9)
2.51% more ownership
Funds ownership: 94.21% → 96.72% (+2.5%)
12% less capital invested
Capital invested by funds: $623M → $548M (-$74.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $273K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$15.3M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.62M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.3M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$3M |
| 5 |
Lazard Asset Management
New York
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$12.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.1M |
| 3 |
Millennium Management
New York
|
-$4.15M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.07M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$2.25M |
AVNS Hedge Fund Activity: Q2 2025 in Review
286 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2025, worth a combined $548M — down 12% from $623M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new AVNS positions and 30 closed out — a net gain of 10 holders — while 96 added to existing stakes and 65 trimmed.
The largest buyer was ExodusPoint Capital Management, adding an estimated $15.3M. The largest seller was Neuberger Berman Group, cutting an estimated $12.8M.
- 286 institutional investors held Avanos Medical (AVNS) as of Q2 2025, up from 277 in Q1 2025.
- Funds reported $548M of Avanos Medical stock for Q2 2025, down 12% quarter-over-quarter.
- 40 funds opened new Avanos Medical positions in Q2 2025 and 30 closed out, a net change of +10 holders.
- The largest Avanos Medical buyer in Q2 2025 was ExodusPoint Capital Management, an estimated $15.3M added.
- The largest Avanos Medical seller in Q2 2025 was Neuberger Berman Group, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2025.